ClinVar

Description

This variant is denoted STK11 c.176C>G at the cDNA level, p.Ser59Cys (S59C) at the protein level, and results in the change of a Serine to a Cysteine (TCT>TGT). This variant has not, to our knowledge, been published in the literature as pathogenic or benign. STK11 Ser59Cys was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, suggesting it is not a common benign variant in these populations. Since Serine and Cysteine differ in polarity, charge, size or other properties, this is considered a non-conservative amino acid substitution. STK11 Ser59Cys occurs at a position that is conserved across species and is located in the domain responsible for binding and orientation of ATP (Hearle 2006). In silico analyses predict that this variant is probably damaging to protein structure and function. Based on currently available evidence, it is unclear whether STK11 Ser59Cys is a pathogenic or benign variant. We consider it to be a variant of uncertain significance.